Evidence map›Paper›PMID 27743990›Full record

ReviewMolecular and cellular endocrinology2017

Ovarian regeneration: The potential for stem cell contribution in the postnatal ovary to sustained endocrine function.

Alisha M Truman, Jonathan L Tilly, Dori C Woods

Registry-linked trialAbstract readReview
In one paragraph

Review in Molecular and cellular endocrinology, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT04444245 (Re-establishment of Ovarian Hormonal Function, Delay of Menopause, or Reversal of Early Menopause With High Density), which is not on this map. Cited by 33 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
33citing papers in PubMed, 1 pooled it
9.4field-weighted citation impact, top 2% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT04444245 phase1unknown statusnot on this mapstarted 2022, after this paper: background citation

Re-establishment of Ovarian Hormonal Function, Delay of Menopause, or Reversal of Early Menopause With High Density (HD PRP), tSVF + PRP, or Cell Enriched tSVF + PRP by Ultrasound Guided Ovarian Injection

TypeinterventionalSponsorBlack Tie Medical, Inc.Ran2022 to 2025Enrolled100ConditionsOvarian Failure, Perimenopausal Disorder, Hormone DisturbanceArmslipoaspiration harvest tSVF, Platelet Rich Plasma, Endovaginal Ultrasound, Cellular Isolation cSVF, Normal Saline (NS) .9% 10 mL Injection
3 · Its place in the literature

Who cites it

33 citing papers in PubMed, 1 synthesis or guideline pooled it, 72 citations in OpenAlex.

  1. Pooled it
  2. Article
  3. Article
  4. Article
  5. Review
  6. The process of ovarian aging: it is not just about oocytes and granulosa cells.Journal of assisted reproduction and genetics · 2022
    Review
  7. Article
  8. Article
  9. Review
  10. Review
  11. Article
  12. Review
  13. Review
  14. Review
  15. Review
  16. Article
  17. Review
  18. Review
  19. Article
  20. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

3 authors at 1 institution in 1 country.

Alisha M TrumanDepartment of Biology, Laboratory of Aging and Infertility Research, Northeastern University, Boston, MA, USA.
Jonathan L TillyDepartment of Biology, Laboratory of Aging and Infertility Research, Northeastern University, Boston, MA, USA.
Dori C WoodsDepartment of Biology, Laboratory of Aging and Infertility Research, Northeastern University, Boston, MA, USA. Electronic address: d.woods@northeastern.edu.
Northeastern University · US

Funding

Origins/Functions of Mammalian Female Germline Stem CellR37AG012279 · NIA · NORTHEASTERN UNIVERSITY · PI TILLY, JONATHAN LEE · 2006 to 2015
$3.3M
Origins and Functions of Mammalian Female Germline Stem CellsR01AG012279 · NIA · NORTHEASTERN UNIVERSITY · PI TILLY, JONATHAN LEE · 1995 to 2021
$2.7M
NIA NIH HHS R01 AG012279NIA NIH HHS R37 AG012279
6 · The paper itself

Abstract

The endocrine function of the ovary is dependent upon the ovarian follicle, which on a cellular basis consists of an oocyte surrounded by adjacent somatic cells responsible for generating sex steroid hormones and maintenance of hormonal stasis with the hypothalamic-pituitary axis. As females age, both fertility and the endocrine function of the ovary decline due to waning follicle numbers as well as aging-related cellular dysfunction. Although there is currently no cure for ovarian failure and endocrine disruption, recent advances in ovarian biology centered on ovarian stem cell and progenitor cell populations have brought the prospects of cell- or tissue-based therapeutic strategies closer to fruition. Herein, we review the relative contributions of ovarian stem cells to ovarian function during the reproductive lifespan, and postulate steps toward the development of ovarian stem cell-based approaches to advance fertility treatments, and also importantly to provide a physiological long-term means of endocrine support.

Indexed as

RegenerationAgingAnimalsFemaleGonadal Steroid HormonesGranulosa CellsHumansOvaryPrimary Ovarian InsufficiencyStem CellsTheca CellsGonadal Steroid HormonesFemale germline stem cellGranulosa cellOSCOvaryStem cells

Identifiers

PMID27743990
PMCPMC5604433
OpenAlexW2530747981

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.